NJR appoints Medical Director
10 January 2014
The National Joint Registry is delighted to announce the appointment of Mr Martyn Porter as NJR Medical Director (MD). The appointment will start on 1 February 2014 and is on a two-day per week basis for a tenure of three years.
This new post has been created to the support the NJR in its future growth. The NJR Medical Director will also serve as the NJR Vice-Chairman and represent NJR Steering Committee
surgeon colleagues on the Executive Committee.
The MD will be central to:
- Growing the clinical appropriateness of NJR’s work programme with particular emphasis on the use of audit data to improve quality of patient care
- Developing NJR strategic aims, objectives and partnerships through greater clinical engagement
- Overseeing the surgeon and hospital outlier processes
- Providing clinical leadership to those orthopaedic surgeons working for and with the NJR at a national and local level
NJR Chairman Laurel Powers-Freeling said: “We are very pleased to welcome Martyn to this new role. His established and extensive knowledge of the registry and its data will serve as an excellent foundation in fulfilling and developing, as required, this new Medical Director post. The demands of the NJR’s work grow rapidly as we seek to provide an ever-improving evidence base for the benefit of patients and the wider orthopaedic sector.”
HQIP Development Lead for the NJR Elaine Young noted: “The new role of Medical Director will be key to strengthening closer working and greater collaboration with the orthopaedic profession, to ensure the continued success and development of the NJR both nationally and internationally in the future. I am delighted that I will be working with Martyn in this capacity.”
Currently an NJR Steering Committee orthopaedic surgeon representative and Chair of the NJR Editorial Board, Martyn added: “I am delighted to be appointed as NJR Medical Director at a time of real momentum for quality information in the health sector. In recent years, we have seen NJR data influence surgical practice for the better and help to put evidence at the heart of decision making. With a growing wealth of registry data, the potential for improvement in orthopaedics is significant and that’s what I am committed to – for surgeons and for patients.”
Martyn Porter’s further biography:
Martyn Porter is immediate Past President of the British Orthopaedic Association. He works as a Consultant Orthopaedic Surgeon at the Centre for Hip Surgery, Wrightington Hospital in Lancashire specialising in complex reconstruction of the hip and knee.
He has been involved in the National Joint Registry of England and Wales since its inception in 2003 sitting on the Steering Committee and for the last five years as Chairman of the Editorial Board.
He has recently published on the adverse outcomes of metal on metal hip replacements in the Lancet and also on the risks of cancer in the British Medical Journal.
He is Past President of the British Hip Society and President Elect of the International Society of Arthroplasty Registers. He is particularly interested in evaluating orthopaedic outcomes and improving quality through national audit.